Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers
Clinical trial NCT04618263 · TERMINATED
Trial details
- NCT number
- NCT04618263
- Sponsor
- Syndeio Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2021-08-13
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.